These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11956611)

  • 1. Breast-conservation treatment for bilateral breast cancer in five Japanese women.
    Hamada N; Ogawa Y; Nishioka A; Kariya S; Terashima M; Yoshida S; Tochika N; Tanaka Y; Kumon M; Inomata T
    Oncol Rep; 2002; 9(3):469-74. PubMed ID: 11956611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
    Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
    Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment.
    Hamada N; Ogawa Y; Saibara T; Murata Y; Kariya S; Nishioka A; Terashima M; Inomata T; Yoshida S
    Int J Oncol; 2000 Dec; 17(6):1119-23. PubMed ID: 11078796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early experiences of breast-conservation treatment combined with tamoxifen and CAF chemotherapy for breast cancer of stages I and II.
    Ogawa Y; Nishioka A; Inomata T; Hamada N; Terashima M; Yoshida S; Tanaka Y; Ogoshi S; Araki K; Kumon M
    Radiat Med; 1994; 12(1):29-35. PubMed ID: 8016401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].
    Jiang Z; Song S; Liu X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):420-2. PubMed ID: 11810777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservation treatment intensified with tamoxifen and CAF chemotherapy for subareolar breast cancers.
    Ogawa Y; Nishioka A; Inomata T; Tsuboi N; Hayase N; Fukumoto M; Yoshida S; Tohchika N; Tanaka Y; Kumon M
    Oncol Rep; 1998; 5(6):1337-41. PubMed ID: 9769365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of recurrent breast cancer with extensive liver metastasis successfully treated with endocrine therapy].
    Kiyoto S; Hara F; Osumi S; Takabatake D; Takashima S; Aogi K; Takashima S
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2623-5. PubMed ID: 20009467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of chemosensitivity and efficacy between pirarubicin and epirubicin in breast cancer].
    Zang MF; Zhang YM; Zhi YH; Zhai Z; Zhang M; Gu F; Zhi XC
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1388-92. PubMed ID: 21756809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
    Rodenhuis S; Richel DJ; van der Wall E; Schornagel JH; Baars JW; Koning CC; Peterse JL; Borger JH; Nooijen WJ; Bakx R; Dalesio O; Rutgers E
    Lancet; 1998 Aug; 352(9127):515-21. PubMed ID: 9716055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection.
    Sanuki-Fujimoto N
    Cancer Treat Rev; 2005 Oct; 31(6):496-500. PubMed ID: 16199127
    [No Abstract]   [Full Text] [Related]  

  • 13. Low proliferative rate of invasive node-negative breast cancer predicts for a favorable outcome: a prospective evaluation of 669 patients.
    Jones S; Clark G; Koleszar S; Ethington G; Mennel R; Paulson S; Brooks B; Kerr R; Denham C; Savin M; White C; Blum J; Kirby R; Stone M; Pippen J; Kitchens L; George T; Cooper B; Peters G; Knox S; Grant M; Cheek H; Jones R; Kuhn J; Lieberman Z; Savino D; Rietz C
    Clin Breast Cancer; 2001 Jan; 1(4):310-4; discussion 315-7. PubMed ID: 11899353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmental mastectomy and tamoxifen alone provide adequate locoregional control of breast cancer in elderly women.
    Yeh S; Tan LR; O'Connell TX
    Am Surg; 1997 Oct; 63(10):854-7. PubMed ID: 9322656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
    Doyle JJ; Neugut AI; Jacobson JS; Grann VR; Hershman DL
    J Clin Oncol; 2005 Dec; 23(34):8597-605. PubMed ID: 16314622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast conservation after induction chemotherapy for locally advanced breast cancer.
    Kling KM; Ostrzega N; Schmit P
    Am Surg; 1997 Oct; 63(10):861-4. PubMed ID: 9322658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial.
    Tominaga T; Kimijima I; Kimura M; Takatsuka Y; Takashima S; Nomura Y; Kasumi F; Yamaguchi A; Masuda N; Noguchi S; Eshima N
    Jpn J Clin Oncol; 2010 Jul; 40(7):627-33. PubMed ID: 20382637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sequencing of adjuvant treatment after surgery for invasive breast cancer].
    Petit T; Claude L; Carrie C
    Cancer Radiother; 2004 Feb; 8(1):54-8. PubMed ID: 15093202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.
    Kaufmann M; Graf E; Jonat W; Eiermann W; Geberth M; Albert US; Gademann G; Conrad B; Stahl K; von Minckwitz G; Schumacher M;
    J Clin Oncol; 2005 Nov; 23(31):7842-8. PubMed ID: 16258087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
    Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
    J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.